Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 11—November 2005

Correction

Correction, Vol. 11, No. 8

Cite This Article

Close

Highlight and copy the desired format.

EID Correction, Vol. 11, No. 8. Emerg Infect Dis. 2005;11(11):1808. https://dx.doi.org/10.3201/eid1111.C11111
AMA Correction, Vol. 11, No. 8. Emerging Infectious Diseases. 2005;11(11):1808. doi:10.3201/eid1111.C11111.
APA (2005). Correction, Vol. 11, No. 8. Emerging Infectious Diseases, 11(11), 1808. https://dx.doi.org/10.3201/eid1111.C11111.

In "Laboratory Exposures to Brucellae and Implications for Bioterrorism" by Pablo Yagupsky and Ellen Jo Baron, an error occurred in the dosage for rifampin prophylaxis. In the second sentence of the fourth paragraph under the heading "Postexposure Prophylaxis," the correct dosage of rifampin is 600 mg once daily.

The corrected text appears in the updated article at http://wwwnc.cdc.gov/eid/article/11/8/04-1197_article.htm.

We regret any confusion this error may have caused.

Cite This Article

DOI: 10.3201/eid1111.C11111

Table of Contents – Volume 11, Number 11—November 2005

TOP